EAY131 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT02465060
Cancer - Lymphoma,
Cancer - Brain,
Cancer - Breast,
Cancer - Gastro,
Cancer - Gastro/ Colorectal,
Cancer - Gastro/ Esophageal,
Cancer - Genitourinary/ Bladder,
Cancer - Genitourinary/ Prostate,
Cancer - Gynecologic/ Ovarian,
Cancer - Head and Neck,
Cancer - Lung,
Cancer - Melanoma,
Cancer - Pancreatic,
Cancer - Rare,
Cancer - Sarcoma,
Cancer - Thyroid
Principal Investigator: Ding Wang, MD
CANCER, ADVANCED, REFRACTORY, SOLID TUMOR, LYMPHOMA, MULTIPLE MYELOMA, MYELOMA, BRAIN, BREAST, LUNG, COLORECTAL, HEAD, NECK, PANCREAS, GASTROINTESTINAL, PROSTATE, BLADDER, CERVICAL, OVARIAN, KIDNEY, GENITOURINARY, ENDOMETRIAL, UTERINE, MELANOMA, THYROID, GALLBLADDER, SARCOMA, GASTRIC
Accepting Participants
